Targeting p120GAP to the plasma membrane can promote the formation of the Ras-p120GAP complex and further reduce the level of active Ras and the activity of the pathway [39–43], and further inhibits the oncogenic potential of tumor growth and movement [11, 36]. The gene discussed is RASA1; the disease is neoplasm.